---
schema_version: "secwatch.filing_event.v1"
accession: "0001564590-22-025922"
form_type: "8-K"
ticker: "ABCL"
cik: "0001703057"
company_name: "AbCellera Biologics Inc."
filed_at: "2022-07-19T23:59:59+00:00"
generated_at: "2026-06-24T12:25:21.379114+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# AbCellera CBO Neil Berkley departs; separation deal includes salary continuation, equity acceleration

## Summary
- Neil Berkley left as Chief Business Officer effective June 29, 2022.
- Receives 12 months base salary ($450,000/yr) paid over 12 months, plus $173,710 cash payment.
- AbCellera accelerates vesting of 17,500 RSUs; shares issued on Aug 11, 2022 after trading restriction.
- Company pays COBRA premiums through July 1, 2023 or earlier if new job obtained.
- Separation agreement includes non-disparagement, non-solicitation, and confidentiality covenants.

## SEC filing metadata
- accession: 0001564590-22-025922
- form_type: 8-K
- ticker: ABCL
- cik: 0001703057
- company_name: AbCellera Biologics Inc.
- filed_at: 2022-07-19T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1703057/000156459022025922/0001564590-22-025922-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1703057/000156459022025922/abcl-8k_20220709.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001564590-22-025922
- JSON: https://secwatch.observer/filing/0001564590-22-025922.json
- Plain text: https://secwatch.observer/filing/0001564590-22-025922.txt

## Key facts
- Executive change
  Neil Berkley departed as Chief Business Officer at AbCellera Biologics Inc..
  - Action: departed
  - Role: Chief Business Officer
  source text: the departure of Neil Berkley, its Chief Business Officer, from the Company effective June 29, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1703057/000156459022025922/0001564590-22-025922-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.